← Eichor
Study identifier: NCT06849609 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

Condition: Amyotrophic Lateral Sclerosis (ALS)  ·  Sponsor: Hong Chen

PhaseEARLY_Phase 1
Planned participants6
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this trial is to evaluate safety and efficacy of intrathecal delivery of VGN-R13 as a treatment of Amyotrophic Lateral Sclerosis (ALS).

This description comes directly from the study's public registry record.

Talk to the study team

Hong Chen  ·  13296508243  ·  chenhong1129@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

TongJi HospitalWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06849609